Fonte: Il Messaggero
According to epidemiologist Pier Luigi Lopalco, the Covid-19 vaccine produced in Pomezia (Rome), by the Advent division of IRBM in partnership with the Jenner Institute of Oxford, is one of those leading the race. IRBM capitalizes on its previous experience in the fight against Ebola; on the other hand the British university had already fought against Mers. The vaccine candidate of Oxford and Pomezia is advantaged because some already known platforms are being utilized for its development: Lopalco refers to viral vectors, then explains how this technology works.
Article by Francesco Marzoli published on Latina Oggi – 20/05/2020